A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC)

PHASE3CompletedINTERVENTIONAL
Enrollment

437

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

May 31, 2010

Study Completion Date

June 30, 2010

Conditions
Non-Small-Cell Lung Cancer
Interventions
DRUG

Zoledronic acid 4 mg

Zoledronic acid 4 mg in 5 mL concentrated solution prepared with 100 mL calcium free infusion solution (0.9 % sodium chloride or 5% glucose solution).

Trial Locations (69)

Unknown

Novartis Investigative Site, Jette

Novartis Investigative Site, Leuven

Novartis Investigative Site, Liège

Novartis Investigative Site, Beijing

Novartis Investigative Site, Guangzhou

Novartis Investigative Site, Shanghai

Novartis Investigative Site, Clamart

Novartis Investigative Site, Clémont

Novartis Investigative Site, Berlin

Novartis Investigative Site, Coburg

Novartis Investigative Site, Cologne

Novartis Investigative Site, Essen

Novartis Investigative Site, Halle

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Heidelberg

Novartis Investigative Site, Leipzig

Novartis Investigative Site, Ludwigsburg

Novartis Investigative Site, Mannheim

Novartis Investigative Site, München

Novartis Investigative Site, Neumünster

Novartis Investigative Site, Trier

Novartis Investigative Site, Ulm

Novartis Investigative Site, Athens

Novartis Investigative Site, Patra - RIO

Novartis Investigative Site, Thessaloniki

Novartis Investigative Site, Budapest

Novartis Investigative Site, Deszk

Novartis Investigative Site, Mátraháza

Novartis Investigative Site, Pécs

Novartis Investigative Site, Bergamo

Novartis Investigative Site, Carpi

Novartis Investigative Site, Catania

Novartis Investigative Site, Como

Novartis Investigative Site, Cosenza

Novartis Investigative Site, Livorno

Novartis Investigative Site, Novara

Novartis Investigative Site, Orbassano

Novartis Investigative Site, Padua

Novartis Investigative Site, Reggio Calabria

Novartis Investigative Site, Rome

Novartis Investigative Site, Taormina

Novartis Investigative Site, 's-Hertogenbosch

Novartis Investigative Site, Amsterdam

Novartis Investigative Site, Eindhoven

Novartis Investigative Site, Hoofddorp

Novartis Investigative Site, Lodz

Novartis Investigative Site, Olsztyn

Novartis Investigative Site, Poznan

Novartis Investigative Site, Warsaw

Novartis Investigative Site, Coimbra

Novartis Investigative Site, Lisbon

Novartis Investigative Site, Porto

Novartis Investigative Site, Seoul

Novartis Investigative Site, Alicante

Novartis Investigative Site, Donostia / San Sebastian

Novartis Investigative Site, Madrid

Novartis Investigative Site, Málaga

Novartis Investigative Site, Sabadell

Novartis Investigative Site, Lin-Ko

Novartis Investigative Site, Taichung

Novartis Investigative Site, Taipei

Novartis Investigative Site, Bangkok

Novartis Investigative Site, Chaingmai

Novartis Investigative Site, Aberdeen

Novartis Investigative Site, Leeds

Novartis Investigative Site, Leicester

Novartis Investigative Site, London

Novartis Investigative Site, Nottingham

Novartis Investigative Site, Sutton

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY